Skip to Main Content
Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Neurology & Pain
  4. Pain Management
  5. Treatment

Treatment

  • Acute Pain (47)
  • Alzheimer's Disease (83)
  • Back Pain (34)
  • Bell's Palsy (1)
  • Chronic Pain (69)
  • Delirium (7)
  • Epilepsy (74)
  • Headache (76)
  • Inflammation (1)
  • Migraine (71)
  • Multiple Sclerosis (20)
  • Neuromuscular (27)
  • Other (70)
  • Pain Management (470)
    • Controlled Substance Prescriptions (211)
    • Opioid Induced Constipation (12)
    • PCA (1)
    • Treatment (440)
      • Acetaminophen (117)
      • Analgesics (25)
      • Anticonvulsants (35)
      • Antidepressants (60)
      • Muscle Relaxants (33)
      • NSAIDs (172)
      • Opioids (269)
  • Parkinson's Disease (27)
  • Resources (250)
  • Restless Legs (15)
  • Seizures (8)
316 - 330 of 440 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Guidelines for Prevention of NSAID-Related Ulcer Complications (2009) November 2011
Article: Gralise (gra-LEEZ), a new extended-release gabapentin for postherpetic neuralgia (PHN) November 2011
Article: reps claim that Duexis is safer than plain NSAIDs November 2011
Commentary: Celexa (Citalopram) and QT Interval Prolongation October 2011
Commentary: New Formulation: Oxecta (Oxycodone) October 2011
Other: Lazanda REMS Program October 2011
Other: Lazanda REMS training and enrollment is available at www.LazandaREMS.com October 2011
Chart: Fentanyl Products for Breakthrough Pain October 2011
Commentary: Folate for Depression October 2011
Article: Reps are filling up sample closets, hoping prescribers will use Deplin to improve the efficacy of antidepressants October 2011
Article: two new opioid formulations, Oxecta and Lazanda October 2011
Article: citalopram doses should not exceed 40 mg/day for anyone...or 20 mg/day for most patients over age 60 October 2011
Commentary: Changes to Acetaminophen Labeling September 2011
Article: changes to OTC Tylenol and other acetaminophen products September 2011
Patient Education: Safe Use of Acetaminophen (Tylenol) August 2011
  • « Prev
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved